Rockefeller Financial Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.02M | Hold |
8,550
| – | – | 0.02% | 227 |
|
|
2017
Q3 | $1.2M | Hold |
8,550
| – | – | 0.02% | 190 |
|
|
2017
Q2 | $1.04M | Sell |
8,550
-707
| -8% | -$86K | 0.02% | 184 |
|
|
2017
Q1 | $1.12M | Hold |
9,257
| – | – | 0.02% | 180 |
|
|
2016
Q4 | $1.13M | Hold |
9,257
| – | – | 0.02% | 185 |
|
|
2016
Q3 | $1.13M | Hold |
9,257
| – | – | 0.02% | 180 |
|
|
2016
Q2 | $1.08M | Hold |
9,257
| – | – | 0.02% | 195 |
|
|
2016
Q1 | $1.29M | Sell |
9,257
-2,888
| -24% | -$402K | 0.03% | 175 |
|
|
2015
Q4 | $2.32M | Sell |
12,145
-3,081
| -20% | -$588K | 0.05% | 147 |
|
|
2015
Q3 | $2.38M | Sell |
15,226
-230,327
| -94% | -$36M | 0.05% | 142 |
|
|
2015
Q2 | $44.4M | Buy |
245,553
+48,546
| +25% | +$8.78M | 0.92% | 36 |
|
|
2015
Q1 | $34.1M | Buy |
197,007
+9,183
| +5% | +$1.59M | 0.74% | 39 |
|
|
2014
Q4 | $34.8M | Buy |
+187,824
| New | +$34.8M | 0.76% | 39 |
|
|
2014
Q3 | – | Sell |
-241,103
| Closed | -$37.7M | – | 609 |
|
|
2014
Q2 | $37.7M | Sell |
241,103
-109,333
| -31% | -$17.1M | 0.85% | 43 |
|
|
2014
Q1 | $53.3M | Buy |
350,436
+1,800
| +0.5% | +$274K | 1.15% | 30 |
|
|
2013
Q4 | $46.3M | Sell |
348,636
-109,196
| -24% | -$14.5M | 1% | 35 |
|
|
2013
Q3 | $53.2M | Sell |
457,832
-49,143
| -10% | -$5.71M | 1.24% | 26 |
|
|
2013
Q2 | $46.8M | Buy |
+506,975
| New | +$46.8M | 1.12% | 29 |
|